SCHEMBL31362601

SCHEMBL31362601

Cc1ccc(S(=O)(=O)OC[C@@H]2CC(=O)N(C)C2)cc1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 9/20 0.44
CYP2D6 P10635 4/20 0.43
CYP1A2 P05177 1/20 0.43
MMP2 P08253 1/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP3A4 P08684 2/20 0.39
TSHR P16473 2/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
VDR P11473 1/20 0.38
MCOLN3 Q8TDD5 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25352929 1.00 BRD4 (0.44) BRD4CYP2D6CYP1A2MMP2ALDH1A1
SCHEMBL10756668 1.00 BRD4 (0.44) BRD4CYP2D6CYP1A2MMP2ALDH1A1
SCHEMBL10757005 0.89 BRD4 (0.40) BRD4CYP2D6CYP1A2ALDH1A1MAPT
SCHEMBL31371773 0.86 CYP2D6 (0.44) CYP2D6CYP1A2MMP2ALDH1A1CYP3A4
SCHEMBL31309741 0.86 CYP2D6 (0.42) CYP2D6CYP1A2MMP2ALDH1A1CYP3A4
SCHEMBL31624936 0.83 CYP2D6 (0.43) CYP2D6CYP1A2MMP2ALDH1A1CYP3A4
SCHEMBL31754953 0.83 CYP2D6 (0.35) BRD4CYP2D6CYP1A2MMP2ALDH1A1
SCHEMBL31754923 0.81 CYP2D6 (0.34) BRD4CYP2D6CYP1A2ALDH1A1CYP3A4
SCHEMBL19950674 0.80 CYP2D6 (0.43) CYP2D6CYP1A2MMP2ALDH1A1CYP3A4
SCHEMBL4835733 0.80 CYP2D6 (0.43) CYP2D6CYP1A2MMP2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025034858-A1 FUSED PYRIDINES FOR THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2025-02-13 WO disclosed